Prolyl isomerase PIN1 regulates DNA double-strand break repair by counteracting DNA end resection

Molecular Cell

Volumn 50, Issue 3, 2013, Pages 333-343

  Steger, Martin ^a   Murina, Olga ^a   Hühn, Daniela ^a   Ferretti, Lorenza P ^a   Walser, Reto ^a   Hänggi, Kay ^a   Lafranchi, Lorenzo ^a   Neugebauer, Christine ^a   Paliwal, Shreya ^a   Janscak, Pavel ^a   Gerrits, Bertran ^a   Del Sal, Giannino ^b,c   Zerbe, Oliver ^a   Sartori, Alessandro A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Laboratorio Nazionale CIB   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDYLPROLYL ISOMERASE PIN1; PLASMID DNA; SMALL INTERFERING RNA; CARRIER PROTEIN; CDK2 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 2; DNA; DNA BINDING PROTEIN; NIMA INTERACTING PEPTIDYLPROLYL ISOMERASE; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; NUCLEAR PROTEIN; PEPTIDYLPROLYL ISOMERASE; RBBP8 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; DNA DEGRADATION; DNA END JOINING REPAIR; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOMERIZATION; MOUSE; NONHUMAN; PHOSPHORYLATION; REGULATORY MECHANISM; UBIQUITINATION; CELL LINE; GENETICS; METABOLISM;

CARRIER PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE 2; DNA; DNA BREAKS, DOUBLE-STRANDED; DNA END-JOINING REPAIR; DNA-BINDING PROTEINS; GENOMIC INSTABILITY; HEK293 CELLS; HOMOLOGOUS RECOMBINATION; HUMANS; NUCLEAR PROTEINS; PEPTIDYLPROLYL ISOMERASE; PHOSPHORYLATION; UBIQUITINATION;

EID: 84883599853     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.03.023     Document Type: Article

References (52)

1. Adachi N., So S., Koyama H. Loss of nonhomologous end joining confers camptothecin resistance in DT40 cells. Implications for the repair of topoisomerase I-mediated DNA damage. J. Biol. Chem. 2004, 279:37343-37348.
2. Aylon Y., Liefshitz B., Kupiec M. The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO J. 2004, 23:4868-4875.
3. Bao L., Kimzey A., Sauter G., Sowadski J.M., Lu K.P., Wang D.-G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164:1727-1737.
4. Bennardo N., Cheng A., Huang N., Stark J.M. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008, 4:e1000110. 10.1371/journal.pgen.1000110.
5. Bennetzen M.V., Larsen D.H., Bunkenborg J., Bartek J., Lukas J., Andersen J.S. Site-specific phosphorylation dynamics of the nuclear proteome during the DNA damage response. Mol. Cell. Proteomics 2010, 9:1314-1323.
6. Bertrand P., Saintigny Y., Lopez B.S. p53's double life: transactivation-independent repression of homologous recombination. Trends Genet. 2004, 20:235-243.
7. Beucher A., Birraux J., Tchouandong L., Barton O., Shibata A., Conrad S., Goodarzi A.A., Krempler A., Jeggo P.A., Löbrich M. ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J. 2009, 28:3413-3427.
8. Bouwman P., Jonkers J. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance. Nat. Rev. Cancer 2012, 12:587-598.
9. Bunting S.F., Callén E., Wong N., Chen H.-T., Polato F., Gunn A., Bothmer A., Feldhahn N., Fernandez-Capetillo O., Cao L., et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010, 141:243-254.
10. Chapman J.R., Taylor M.R.G., Boulton S.J. Playing the end game: DNA double-strand break repair pathway choice. Mol. Cell 2012, 47:497-510.
11. Chen L., Nievera C.J., Lee A.Y.-L., Wu X. Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair. J. Biol. Chem. 2008, 283:7713-7720.
12. Ciccia A., Elledge S.J. The DNA damage response: making it safe to play with knives. Mol. Cell 2010, 40:179-204.
13. Di Virgilio M., Callen E., Yamane A., Zhang W., Jankovic M., Gitlin A.D., Feldhahn N., Resch W., Oliveira T.Y., Chait B.T., et al. Rif1 prevents resection of DNA breaks and promotes immunoglobulin class switching. Science 2013, 339:711-715.
14. Eid W., Steger M., El-Shemerly M., Ferretti L.P., Peña-Diaz J., König C., Valtorta E., Sartori A.A., Ferrari S. DNA end resection by CtIP and exonuclease 1 prevents genomic instability. EMBO Rep. 2010, 11:962-968.
15. Goodarzi A.A., Jeggo P., Löbrich M. The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax. DNA Repair (Amst.) 2010, 9:1273-1282.
16. Gravel S., Chapman J.R., Magill C., Jackson S.P. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 2008, 22:2767-2772.
17. Helleday T. Homologous recombination in cancer development, treatment and development of drug resistance. Carcinogenesis 2010, 31:955-960.
18. Heyer W.-D., Ehmsen K.T., Liu J. Regulation of homologous recombination in eukaryotes. Annu. Rev. Genet. 2010, 44:113-139.
19. Huertas P., Cortés-Ledesma F., Sartori A.A., Aguilera A., Jackson S.P. CDK targets Sae2 to control DNA-end resection and homologous recombination. Nature 2008, 455:689-692.
20. Ira G., Pellicioli A., Balijja A., Wang X., Fiorani S., Carotenuto W., Liberi G., Bressan D., Wan L., Hollingsworth N.M., et al. DNA end resection, homologous recombination and DNA damage checkpoint activation require CDK1. Nature 2004, 431:1011-1017.
21. Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
22. Johnson N., Cai D., Kennedy R.D., Pathania S., Arora M., Li Y.-C., D'Andrea A.D., Parvin J.D., Shapiro G.I. Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage. Mol. Cell 2009, 35:327-339.
23. Jowsey P., Morrice N.A., Hastie C.J., McLauchlan H., Toth R., Rouse J. Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR. DNA Repair (Amst.) 2007, 6:1536-1544.
24. Karanam K., Kafri R., Loewer A., Lahav G. Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase. Mol. Cell 2012, 47:320-329.
25. Karanja K.K., Cox S.W., Duxin J.P., Stewart S.A., Campbell J.L. DNA2 and EXO1 in replication-coupled, homology-directed repair and in the interplay between HDR and the FA/BRCA network. Cell Cycle 2012, 11:3983-3996.
26. Kousholt A.N., Fugger K., Hoffmann S., Larsen B.D., Menzel T., Sartori A.A., Sørensen C.S. CtIP-dependent DNA resection is required for DNA damage checkpoint maintenance but not initiation. J. Cell Biol. 2012, 197:869-876.
27. Krishnan N., Lam T.T., Fritz A., Rempinski D., O'Loughlin K., Minderman H., Berezney R., Marzluff W.F., Thapar R. The prolyl isomerase Pin1 targets stem-loop binding protein (SLBP) to dissociate the SLBP-histone mRNA complex linking histone mRNA decay with SLBP ubiquitination. Mol. Cell. Biol. 2012, 32:4306-4322.
28. Liou Y.-C., Zhou X.Z., Lu K.P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 2011, 36:501-514.
29. Lippens G., Landrieu I., Smet C. Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1. FEBS J. 2007, 274:5211-5222.
30. Manke I.A., Nguyen A., Lim D., Stewart M.Q., Elia A.E.H., Yaffe M.B. MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. Mol. Cell 2005, 17:37-48.
31. Marcucci R., Brindle J., Paro S., Casadio A., Hempel S., Morrice N., Bisso A., Keegan L.P., Del Sal G., O'Connell M.A. Pin1 and WWP2 regulate GluR2 Q/R site RNA editing by ADAR2 with opposing effects. EMBO J. 2011, 30:4211-4222.
32. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
33. Meerang M., Ritz D., Paliwal S., Garajova Z., Bosshard M., Mailand N., Janscak P., Hübscher U., Meyer H., Ramadan K. The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat. Cell Biol. 2011, 13:1376-1382.
34. Patel A.G., Sarkaria J.N., Kaufmann S.H. Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells. Proc. Natl. Acad. Sci. USA 2011, 108:3406-3411.
35. Phan R.T., Saito M., Kitagawa Y., Means A.R., Dalla-Favera R. Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. Nat. Immunol. 2007, 8:1132-1139.
36. Pommier Y. Topoisomerase I inhibitors: camptothecins and beyond. Nat. Rev. Cancer 2006, 6:789-802.
37. Reinhardt H.C., Aslanian A.S., Lees J.A., Yaffe M.B. p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. Cancer Cell 2007, 11:175-189.
38. Rouleau M., Patel A., Hendzel M.J., Kaufmann S.H., Poirier G.G. PARP inhibition: PARP1 and beyond. Nat. Rev. Cancer 2010, 10:293-301.
39. Rustighi A., Tiberi L., Soldano A., Napoli M., Nuciforo P., Rosato A., Kaplan F., Capobianco A., Pece S., Di Fiore P.P., Del Sal G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 2009, 11:133-142.
40. Sartori A.A., Lukas C., Coates J., Mistrik M., Fu S., Bartek J., Baer R., Lukas J., Jackson S.P. Human CtIP promotes DNA end resection. Nature 2007, 450:509-514.
41. Shibata A., Conrad S., Birraux J., Geuting V., Barton O., Ismail A., Kakarougkas A., Meek K., Taucher-Scholz G., Löbrich M., Jeggo P.A. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 2011, 30:1079-1092.
42. Silverman J.S., Skaar J.R., Pagano M. SCF ubiquitin ligases in the maintenance of genome stability. Trends Biochem. Sci. 2012, 37:66-73.
43. Söderberg O., Gullberg M., Jarvius M., Ridderstråle K., Leuchowius K.-J., Jarvius J., Wester K., Hydbring P., Bahram F., Larsson L.-G., Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 2006, 3:995-1000.
44. Stukenberg P.T., Kirschner M.W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol. Cell 2001, 7:1071-1083.
45. Ubersax J.A., Ferrell J.E. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 2007, 8:530-541.
46. van den Heuvel S., Harlow E. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 1993, 262:2050-2054.
47. Wang Y., Liu C., Yang D., Yu H., Liou Y.-C. Pin1At encoding a peptidyl-prolyl cis/trans isomerase regulates flowering time in Arabidopsis. Mol. Cell 2010, 37:112-122.
48. Yaffe M.B., Schutkowski M., Shen M., Zhou X.Z., Stukenberg P.T., Rahfeld J.U., Xu J., Kuang J., Kirschner M.W., Fischer G., et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278:1957-1960.
49. Yu X., Fu S., Lai M., Baer R., Chen J. BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP. Genes Dev. 2006, 20:1721-1726.
50. Yuan W.-C., Lee Y.-R., Huang S.-F., Lin Y.-M., Chen T.-Y., Chung H.-C., Tsai C.-H., Chen H.-Y., Chiang C.-T., Lai C.-K., et al. A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression. Cancer Cell 2011, 20:214-228.
51. Zacchi P., Gostissa M., Uchida T., Salvagno C., Avolio F., Volinia S., Ronai Z., Blandino G., Schneider C., Del Sal G. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419:853-857.
52. Zheng H., You H., Zhou X.Z., Murray S.A., Uchida T., Wulf G., Gu L., Tang X., Lu K.P., Xiao Z.-X.J. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419:849-853.